Proceedings of the National Academy of Sciences · 2020 · 40 citations · 38 references
MedicineMolecular BiologyOncologyCancer GeneticsGene ExpressionMolecular OncologyAlternative SplicingCancer Cell SignalingCancer ImmunotherapyCancer Stem Cell BiologyCancer Stem CellsSignal Transduction In CancerAlternative Splicing RegulationCancer Stem Cell - Mediated ResistanceCancer Stem Cell TargetingCancer Stem Cell-mediated ResistanceCancer Stem-like CellsCancer-associated SplicingJnk Pathway ActivationTherapy-resistant Cancer Stem Cells
Significance Targeting stem-like cells in cancer is critical to overcoming resistance and relapse post chemotherapy or immunotherapy. We elucidate an alternative-splicing driven mechanism of cancer dedifferentiation and define a molecular context wherein stem-like tumor cells show enhanced susceptibility to JNK inhibition. MBNL1 and MAP2K7 ∆exon2 can prognosticate patients for JNK inhibition that can render stem-like tumor cells susceptible to therapy.
38
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin, Carrie Davis, Felix Schlesinger et al. · Bioinformatics · 2012 · 56.2K citations · Full text
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis, Sohrab P. Shah, Suet‐Feung Chin et al. · Nature · 2012 · 6.4K citations · Full text
Life Sciences, Genetics, Oncology +14
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang, Rickard Sandberg, Shujun Luo et al. · Nature · 2008 · 5.4K citations · Full text